Insilico Medicine, the parent company of Skolkovo biomed startup Insilico, has launched a beta 1.0 version of a system that will study aging at the population level and track the efficacy of anti-aging interventions, and could one day help to prevent diseases...
UNIM , a resident startup of the Skolkovo Foundation’s biomed cluster that provides remote cancer diagnosis services, has raised investment from Medme, a strategic investor on the digital medicine market. Under the terms of the deal, the details of which...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
Fourteen Skolkovo biomed startups are currently taking part in the BIO International Convention 2017 in San Diego, California. The four-day convention, which began on June 19, is devoted to the research and development of innovative healthcare, agricultural...
The Skolkovo Foundation announced the official launch of Skolkovo Ventures – three new investment funds devoted to IT, industrial technology and biotech – at the Startup Village open-air conference on Tuesday. The investment funds have been set...
Первый научно-исследовательский центр в России компании Philips открылся в Инновационном центре «Сколково». Об этом было объявлено на проходящей в иннограде конференции Startup Village . Президент «Сколково» Виктор Вексельберг вручил...
The founders and directors of Skolkovo resident startups make up nearly one-third of a list of “ 20 young and promising heroes of tomorrow ” published by the RBC news agency’s magazine on Thursday. Six of the 20 inventors and entrepreneurs...
Ведущий кубинский биомедицинский концерн BioCubaFarma назначил регионального представителя в России. Выпускница биофака МГУ Идания Кабальеро Торрес будет представлять в Москве интересы 31 компании и 64 производственных объединений, входящих в Группу BioCubaFarma...
The Skolkovo Foundation has signed a strategic partnership agreement with the multinational pharmaceuticals giant AstraZeneca to carry out joint scientific research and educational activities in Russia. Irina Panarina, director of AstraZeneca Russia and...
SL Onkolodzhi , a Skolkovo resident startup working on a cancer vaccine, has successfully completed phase I/IIa clinical trials together with its U.S. partner, CureLab Oncology, Inc . The two companies have developed a cancer vaccine called Elenagen™...
Half of all Russian-origin innovative pharmaceuticals are developed by Skolkovo Foundation startups, Kirill Kaem, head of the organisation’s biomed cluster, told a meeting of the foundation’s council on Monday evening. Of about 1,400 pharmaceuticals...
Infectex , a resident of the Skolkovo Foundation’s biomed cluster, has completed clinical trials in Russia of its new drug for treating TB, the company announced on Friday, World Tuberculosis Day. The drug – SQ109 – has demonstrated high...
The Open Innovations Startup Tour 2017 , a roving search for talented tech startups across Russia and several neighbouring countries, has completed its first stop abroad in the Kazakh city of Almaty, following earlier visits to Russia’s Far Eastern regions...
Two Skolkovo resident startups were included in the TekhUspekh (TechUp) rating of fast-growing Russian tech companies announced at Moscow State University last week. Eidos ( Ensim ), which makes surgery simulators for training surgeons and medical students...
A company working on creating food for prawns from algae has been awarded five million rubles ($82,000) by the Skolkovo Foundation, making it the first startup working in agriculture to receive a mini-grant from the foundation. The company, Solixant , plans...
Skolkovo’s Technopark has signed an agreement with Cherkizovo Group, a major Russian meat producer, to establish an acceleration centre for Skolkovo resident startups working in the areas of biotech in agriculture and industry. Renat Batyrov, left...
Одна из крупнейших аграрных компаний России подписала соглашение о сотрудничестве с Технопарком «Сколково». Документ предусматривает создание Акселерационного центра, в котором эксперты «Черкизово» будут выступать в качестве менторов...
ХАЙФА, ИЗРАИЛЬ. Через несколько дней после того, как «Сколково» подписал первое в своей истории соглашение о сотрудничестве с зарубежным городом – израильским Йокнеам-Илит, – биомедицинский кластер Фонда начинает бизнес-миссию в Израиль...
На политической карте мира израильский город Йокнеам-Илит возник в 1950 году. На исторической карте – двумя тысячелетиями ранее: его первое упоминание содержится в Ветхом Завете, в Книге Иисуса Навина. На технологической карте мира город с населением...
The head of Skolkovo resident startup Motorica , which makes hi-tech prostheses, has been awarded the Made in Russia prize for science and technology organised by Snob magazine. Motorica director Ilya Chekh pictured at the Skolkovo innovation centre earlier...
The Skolkovo Foundation has signed a cooperation agreement with BioCubaFarma, Cuba’s biggest biotech company, continuing a series of agreements and mutual visits between the foundation and the island nation. Prime Minister Dmitry Medvedev, right...
Finland’s BioCity Technopark is to build a biotech technopark at the Skolkovo innovation centre under an agreement signed Tuesday at the ongoing International Association of Science Parks and Areas of Innovation (IASP) conference in Moscow. Kirill...
3D Bioprinting Solutions , a resident company of the Skolkovo Foundation that made headlines last year when it printed the world’s first functional thyroid construct for a mouse, is to make a 3D bioprinter for printing tissue and organ constructs on board...
DRD Biotech , a resident company of the Skolkovo Foundation that makes rapid tests for diagnosing strokes and other conditions affecting the brain, won second prize at the Asian Entrepreneurship Award in Tokyo this week, taking home 500,000 yen ($4,700). ...
As the world discusses the ethics of growing human organs in pigs , scientists gathered at the Skolkovo Foundation last week to discuss an equally divisive topic: that of human genome modification. Scientists in the U.S. are currently making headlines...